Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7-day vs 14-day Vonoprazan-based Triple Therapy for H. Pylori in Adolescents
NCT06576882Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Jun 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in Helicobacter pylori infection, sponsored by Alexandria University. Started Jun 2024; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06576882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06576882.